104 related articles for article (PubMed ID: 9403002)
1. Allelic loss of the FMS gene in acute myeloid leukaemia.
McGlynn H; Kapelko K; Baker A; Burnett A; Padua RA
Leuk Res; 1997 Oct; 21(10):919-23. PubMed ID: 9403002
[TBL] [Abstract][Full Text] [Related]
2. c-fms point mutations in acute myeloid leukemia: fact or fiction?
Springall F; O'Mara S; Shounan Y; Todd A; Ford D; Iland H
Leukemia; 1993 Jul; 7(7):978-85. PubMed ID: 8321048
[TBL] [Abstract][Full Text] [Related]
3. Expression of the c-fgr and hck protein-tyrosine kinases in acute myeloid leukemic blasts is associated with early commitment and differentiation events in the monocytic and granulocytic lineages.
Willman CL; Stewart CC; Longacre TL; Head DR; Habbersett R; Ziegler SF; Perlmutter RM
Blood; 1991 Feb; 77(4):726-34. PubMed ID: 1825181
[TBL] [Abstract][Full Text] [Related]
4. M-CSF and M-CSF-receptor gene expression in acute myelomonocytic leukemias.
Parwaresch MR; Kreipe H; Felgner J; Heidorn K; Jaquet K; Bödewadt-Radzun S; Radzun HJ
Leuk Res; 1990; 14(1):27-37. PubMed ID: 2154646
[TBL] [Abstract][Full Text] [Related]
5. Deletion of the acetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML).
Stephenson J; Czepulkowski B; Hirst W; Mufti GJ
Leuk Res; 1996 Mar; 20(3):235-41. PubMed ID: 8637218
[TBL] [Abstract][Full Text] [Related]
6. Rare point mutation at codon 301 and 969 of FMS/M-CSF receptor in acute myelomonocytic and monocytic leukemia.
Natazuka T; Matsui T; Ito M; Nakata H; Nakagawa T; Nakamura H; Masaoka T; Isobe T; Nakao Y
Leuk Res; 1992; 16(5):541-3. PubMed ID: 1385636
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two reverse transcription-polymerase chain reaction methods for detection of AML1/ETO rearrangement in the M2 subtype of acute myeloid leukaemia.
Barragán E; Bonanad S; López JA; Bolufer P; Sanz MA
Clin Chem Lab Med; 1998 Mar; 36(3):137-42. PubMed ID: 9589800
[TBL] [Abstract][Full Text] [Related]
8. Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia.
Christiansen DH; Andersen MK; Desta F; Pedersen-Bjergaard J
Leukemia; 2005 Dec; 19(12):2232-40. PubMed ID: 16281072
[TBL] [Abstract][Full Text] [Related]
9. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
[TBL] [Abstract][Full Text] [Related]
10. ras oncogene activation and occupational exposures in acute myeloid leukemia.
Taylor JA; Sandler DP; Bloomfield CD; Shore DL; Ball ED; Neubauer A; McIntyre OR; Liu E
J Natl Cancer Inst; 1992 Nov; 84(21):1626-32. PubMed ID: 1433344
[TBL] [Abstract][Full Text] [Related]
11. Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion.
Boultwood J; Rack K; Kelly S; Madden J; Sakaguchi AY; Wang LM; Oscier DG; Buckle VJ; Wainscoat JS
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6176-80. PubMed ID: 1829836
[TBL] [Abstract][Full Text] [Related]
12. Analysis of ras gene mutations in acute myeloid leukemia by the polymerase chain reaction and oligonucleotide probes.
Chin YM; Bosco JJ; Koh CL
Singapore Med J; 1992 Feb; 33(1):48-50. PubMed ID: 1598607
[TBL] [Abstract][Full Text] [Related]
13. Clonal analysis of multiple point mutations in the N-ras gene in patients with acute myeloid leukemia.
Kubo K; Naoe T; Kiyoi H; Fukutani H; Kato Y; Oguri T; Yamamori S; Akatsuka Y; Kodera Y; Ohno R
Jpn J Cancer Res; 1993 Apr; 84(4):379-87. PubMed ID: 8514604
[TBL] [Abstract][Full Text] [Related]
14. Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA.
Jilani I; Estey E; Manshuri T; Caligiuri M; Keating M; Giles F; Thomas D; Kantarjian H; Albitar M
Leukemia; 2003 Jan; 17(1):114-9. PubMed ID: 12529667
[TBL] [Abstract][Full Text] [Related]
15. In vitro efficacy of l-asparaginase in childhood acute myeloid leukaemia.
Okada S; Hongo T; Yamada S; Watanabe C; Fujii Y; Ohzeki T; Horikoshi Y; Ito T; Yazaki M; Komada Y; Tawa A
Br J Haematol; 2003 Dec; 123(5):802-9. PubMed ID: 14632770
[TBL] [Abstract][Full Text] [Related]
16. Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples.
Shih LY; Liang DC; Huang CF; Chang YT; Lai CL; Lin TH; Yang CP; Hung IJ; Liu HC; Jaing TH; Wang LY; Yeh TC
Leukemia; 2008 Feb; 22(2):303-7. PubMed ID: 17960171
[TBL] [Abstract][Full Text] [Related]
17. Detection of fms-oncogene-specific tyrosine kinase activity in human leukemia cells.
Tamura T; Brost H; Käbisch A; Lampert F; Hadwiger-Fangmeier A; Niemann H
J Cancer Res Clin Oncol; 1989; 115(3):235-41. PubMed ID: 2526817
[TBL] [Abstract][Full Text] [Related]
18. c-fms expression is a molecular marker of human acute myeloid leukemias.
Dubreuil P; Torrès H; Courcoul MA; Birg F; Mannoni P
Blood; 1988 Sep; 72(3):1081-5. PubMed ID: 2970873
[TBL] [Abstract][Full Text] [Related]
19. Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia.
Shih LY; Huang CF; Wang PN; Wu JH; Lin TL; Dunn P; Kuo MC
Leukemia; 2004 Mar; 18(3):466-75. PubMed ID: 14737077
[TBL] [Abstract][Full Text] [Related]
20. Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children.
Xu F; Taki T; Yang HW; Hanada R; Hongo T; Ohnishi H; Kobayashi M; Bessho F; Yanagisawa M; Hayashi Y
Br J Haematol; 1999 Apr; 105(1):155-62. PubMed ID: 10233379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
